(Q40720095)

23 September 2017

Characterization of the anti-HIV effects of native lactoferrin and other milk proteins and protein-derived peptides (English)

1 reference

23 September 2017

Ben Berkhout

1

1 reference

23 September 2017

Jeroen L B van Wamel

2

1 reference

23 September 2017

Leonie Beljaars

3

1 reference

23 September 2017

Dirk K F Meijer

4

1 reference

23 September 2017

Servaas Visser

5

1 reference

23 September 2017

René Floris

6

1 reference

23 September 2017

1 August 2002

1 reference

23 September 2017

1 reference

23 September 2017

55

1 reference

23 September 2017

2

1 reference

23 September 2017

341-355

1 reference

Oral dextran sulfate (UA001) in the treatment of the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex.

23 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

Structural and functional analysis of negatively charged milk proteins with anti-HIV activity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

Lactoferrin: a multifunctional immunoregulatory protein?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

Resistance of the human immunodeficiency virus to the inhibitory action of negatively charged albumins on virus binding to CD4

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

Functionality of beta-casein peptides: importance of amphipathicity for emulsion-stabilizing properties

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

The fusion domain of HIV gp41 interacts specifically with heparan sulfate on the T-lymphocyte cell surface

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

Specific interaction of CCR5 amino-terminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

Improved envelope function selected by long-term cultivation of a translation-impaired HIV-1 mutant

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

Crystal structure of chemically synthesized [N33A] stromal cell-derived factor 1alpha, a potent ligand for the HIV-1 "fusin" coreceptor

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

HIV-1 membrane fusion: targets of opportunity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

Development of resistance of human immunodeficiency virus type 1 to dextran sulfate associated with the emergence of specific mutations in the envelope gp120 glycoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

Phenotype-associated env gene variation among eight related human immunodeficiency virus type 1 clones: evidence for in vivo recombination and determinants of cytotropism outside the V3 domain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

Inhibition of plating of human T cell leukemia virus type I and syncytium-inducing types of human immunodeficiency virus type 1 by polycations

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

Inhibition with lactoferrin of in vitro infection with human herpes virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

HIV type I envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ coreceptors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

Characterization of antiviral activity of lactoferrin against hepatitis C virus infection in human cultured cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

HIV-1--co-receptors binding

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

Entry of R5X4 and X4 human immunodeficiency virus type 1 strains is mediated by negatively charged and tyrosine residues in the amino-terminal domain and the second extracellular loop of CXCR4.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

Loss of a single N-linked glycan allows CD4-independent human immunodeficiency virus type 1 infection by altering the position of the gp120 V1/V2 variable loops

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

Mechanism of anti-HIV activity of negatively charged albumins: biomolecular interaction with the HIV-1 envelope protein gp120

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

Determinants of CD4 independence for a human immunodeficiency virus type 1 variant map outside regions required for coreceptor specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

CD4-independent use of Rhesus CCR5 by human immunodeficiency virus Type 2 implicates an electrostatic interaction between the CCR5 N terminus and the gp120 C4 domain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

Microbicides in HIV prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

A human milk factor susceptible to cathepsin D inhibitors enhances human immunodeficiency virus type 1 infectivity and allows virus entry into a mammary epithelial cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

A milk protein lactoferrin enhances human T cell leukemia virus type I and suppresses HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

Bovine beta-lactoglobulin modified by 3-hydroxyphthalic anhydride blocks the CD4 cell receptor for HIV

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

HIV/AIDS programmes should focus on improved access

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

N-Linked Glycosylation of the HIV Type-1 gp120 Envelope Glycoprotein as a Major Determinant of CCR5 and CXCR4 Coreceptor Utilization

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

Antiviral effect of bovine lactoferrin saturated with metal ions on early steps of human immunodeficiency virus type 1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

Two ion-exchange chromatographic methods for the isolation of antibacterial peptides from lactoferrin. In situ enzymatic hydrolysis on an ion-exchange membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

Identification of two distinct antibacterial domains within the sequence of bovine alpha(s2)-casein

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

Mediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope gp120-gp41.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

The ability of HIV type 1 to use CCR-3 as a coreceptor is controlled by envelope V1/V2 sequences acting in conjunction with a CCR-5 tropic V3 loop

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

Host cyclophilin A mediates HIV-1 attachment to target cells via heparans

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

Antirotaviral activity of milk proteins: lactoferrin prevents rotavirus infection in the enterocyte-like cell line HT-29.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

Conversion of alpha-lactalbumin to a protein inducing apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

Maleylated human serum albumin inhibits HIV-1 infection in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

Dextran sulphate, a potent anti-HIV agent in vitro having synergism with zidovudine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

HIV-1 attachment: another look.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

Peptide substrates for chymosin (rennin). Isolation and substrate behaviour of two tryptic fragments of bovine kappa casein

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

Characterization of bovine kappa-casein fractions and the kinetics of chymosin-induced macropeptide release from carbohydrate-free and carbohydrate-containing fractions determined by high-performance gel-permeation chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

The antigenic structure of the HIV gp120 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900069-4

7 January 2021

10.1016/S0166-3542(02)00069-4

Identifiers

DOI

1 reference

23 September 2017

1 reference